Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

SUMMARY: In a 2-year randomized, placebo-controlled study of 665 Japanese patients with primary osteoporosis, once-yearly administration of zoledronic acid (5 mg) reduced the risk of new morphometric vertebral fractures. INTRODUCTION: The purpose of this study was to determine the efficacy and safet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Osteoporos Int
Main Authors: Nakamura, T., Fukunaga, M., Nakano, T., Kishimoto, H., Ito, M., Hagino, H., Sone, T., Taguchi, A., Tanaka, S., Ohashi, M., Ota, Y., Shiraki, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer London 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5206287/
https://ncbi.nlm.nih.gov/pubmed/27631091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-016-3736-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados